Growth Metrics

Neuroone Medical Technologies (NMTC) Total Debt (2010 - 2024)

Neuroone Medical Technologies posted quarterly Total Debt of $121896.0 for Q1 2024, down 5.59% on a QoQ basis from $129116.0 in Q3 2023.

Neuroone Medical Technologies (NMTC) has 9 years of Total Debt data on file, last reported at $121896.0 in Q1 2024.

  • For the quarter ending Q1 2024, Total Debt changed N/A year-over-year to $121896.0; the trailing twelve-month figure through Mar 2024 stood at $121896.0 (changed N/A YoY), and the FY2023 full-year result was $129116.0, changed N/A from the prior year.
  • Total Debt for Q1 2024 stood at $121896.0, down from $129116.0 in the prior quarter.
  • Across five years, Total Debt topped out at $129116.0 in Q3 2023 and bottomed at $121896.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 34.05 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.72 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 28.07 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 11.03 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 598.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.93 Bn
10 Neuroone Medical Technologies 31.39 Mn 28.59 Mn 1.29 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 121,896.00
Sep 30, 2023 129,116.00
Sep 30, 2019 528,000.00
Jun 30, 2019 528,000.00
Mar 31, 2019 757,000.00
Dec 31, 2018 1.06 Mn
Sep 30, 2018 283,000.00
Jun 30, 2018 2.07 Mn
Mar 31, 2018 369,124.00
Dec 31, 2017 253,000.00
Sep 30, 2017 204,074.00
Dec 31, 2016 50,000.00
Sep 30, 2012 12,500.00
Jun 30, 2012 12,500.00
Mar 31, 2012 12,500.00
Dec 31, 2011 12,500.00
Dec 31, 2010 10,500.00